Clinical Trial Details
— Status: Completed
Administrative data
| NCT number |
NCT04419701 |
| Other study ID # |
pain in knee arthroplasty |
| Secondary ID |
|
| Status |
Completed |
| Phase |
N/A
|
| First received |
|
| Last updated |
|
| Start date |
June 30, 2020 |
| Est. completion date |
January 15, 2021 |
Study information
| Verified date |
June 2020 |
| Source |
Tanta University |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Interventional
|
Clinical Trial Summary
Effective pain relief allows the patients to obtain early knee mobilization and optimal
rehabilitation and thus improves the patient satisfaction.
The aim of perioperative pain control is to minimize delays in recovery, postoperative
delirium and pain-related stress responses that can lead to serious morbidity and poor
outcomes. Numerous approaches to effectively control postoperative pain in TKA patients have
been evaluated, as poorly controlled acute postoperative pain can be associated with
persistent pain. Furthermore, increased pain intensity after surgery on the second knee seems
to be closely associated with chronic post-TKA pain, with similar mechanisms underlying
hyperalgesia or chronic pain.
Description:
Total knee arthroplasty (TKA), one of the most commonly performed operations in orthopaedic
department, has been a successful intervention for patients with end-stage knee arthritis.
Rehabilitation after total knee arthroplasty (TKA) routinely starts immediately after surgery
on the postoperative ward and therefore requires adequate analgesia. An ideal analgesic
modality for post-TKA rehabilitation should permit adequate knee flexion with minimal pain
without motor impairment, resulting in successful mobilization. Pain control plays an
essential role in the overall postoperative period for the patients undergoing TKA.
Effective pain relief allows the patients to obtain early knee mobilization and optimal
rehabilitation and thus improves the patient satisfaction.
The aim of perioperative pain control is to minimize delays in recovery, postoperative
delirium and pain-related stress responses that can lead to serious morbidity and poor
outcomes. Numerous approaches to effectively control postoperative pain in TKA patients have
been evaluated, as poorly controlled acute postoperative pain can be associated with
persistent pain. Furthermore, increased pain intensity after surgery on the second knee seems
to be closely associated with chronic post-TKA pain, with similar mechanisms underlying
hyperalgesia or chronic pain.
Traditionally, the degree of knee flexion has been used as an outcome measure after TKA to
evaluate functional recovery and the success of the type of analgesia used.
Several methods such as intravenous opioids, extraarticular and intraarticular injection,
epidural analgesia and femoral or sciatic nerve blocks are currently used for postoperative
pain management.
However, each method is reported with potential side effects, for example, opioid drugs
caused vomiting, nausea, constipation, dizziness and urinary retention, epidural analgesia
with urinary retention, respiratory depression and spinal headache, femoral or sciatic block
with diminished muscle control and possible nerve damage.
Periarticular multimodal drug injection in TKA is a technique that patients received
intraoperative drug injection in the periarticular fields such as posterior capsule, medial
and lateral collateral ligaments, quadriceps mechanism and peripatellar tissue at the end of
the surgery. Multimodal drugs mainly consist of local anaesthetics, non-steroidal
anti-inflammatory drugs, opioids, epinephrine with or without corticosteroid.
Genicular nerve block (GNB) and ablation have been used for managing chronic pain from knee
osteoarthritis with good success.